Clinical Trial Update: A Study to Assess the Treatment of Obstructive Hypertrophic Cardiomyopathy (oHCM) With Mavacamten in the US

View source ↗

Summary

A clinical trial update indicates that a study evaluating mavacamten for obstructive hypertrophic cardiomyopathy in the United States is currently active but no…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obstructive Hypertrophic Cardiomyopathy

Drugs mentioned

• CAMZYOS (MAVACAMTEN)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Obstructive Hypertrophic Cardiomyopathy (oHCM) | Status: ACTIVE_NOT_RECRUITING